Insider · CIK 0001250661
CORRIGAN MARK
Reports to the SEC for 9 companies · CAMBRIDGE, MA
Transactions
50
Companies
9
Filings
15
CIK
0001250661
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-10-05 | WVEWave Life Sciences, Inc. · Stock Option (right to buy)A Award | — |
| 2026-10-05 | WVEWave Life Sciences, Inc.A Award | — |
| 2025-12-08 | WVEWave Life Sciences, Inc.S Sale | −$126K |
| 2025-12-08 | WVEWave Life Sciences, Inc.S Sale | −$91.6K |
| 2025-08-11 | WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award | — |
| 2025-08-11 | WVEWave Life Sciences, Inc.A Award | — |
| 2024-08-12 | WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award | — |
| 2024-08-12 | WVEWave Life Sciences, Inc.A Award | — |
| 2024-06-13 | TREVENA INCStock Option (Right to Buy)A Award | — |
| 2023-08-07 | WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award | — |
| 2023-07-18 | TREVENA INCStock Option (Right to Buy)A Award | — |
| 2022-08-15 | WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award | — |
| 2022-08-02 | Nabriva Therapeutics plcS Sale | −$1,956.43 |
| 2021-08-16 | WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award | — |
| 2021-07-28 | Nabriva Therapeutics plcA Award | — |
| 2021-07-28 | Nabriva Therapeutics plcShare OptionsA Award | — |
| 2021-06-02 | Nabriva Therapeutics plcShare OptionsA Award | — |
| 2020-08-18 | WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award | — |
| 2019-09-04 | WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award | — |
| 2019-07-31 | Nabriva Therapeutics plcStock OptionA Award | — |
| 2018-08-09 | NOVELION THERAPEUTICS INC.Stock Option (Right to Buy)A Award | — |
| 2018-05-02 | Nabriva Therapeutics plcStock OptionA Award | — |
| 2017-09-15 | Nabriva Therapeutics plcStock OptionA Award | — |
| 2017-06-23 | Nabriva Therapeutics Legacy plcStock OptionJ Other | — |
| 2017-06-23 | Nabriva Therapeutics Legacy plcStock OptionJ Other | — |
| 2017-03-30 | NOVELION THERAPEUTICS INC.Stock Option (Right to Buy)A Award | — |
| 2017-03-30 | NOVELION THERAPEUTICS INC.Stock Option (Right to Buy)A Award | — |
| 2017-03-01 | CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer | −$347K |
| 2017-03-01 | CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer | −$358K |
| 2016-05-10 | CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award | — |
| 2015-10-27 | CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award | — |
| 2015-06-05 | EPIRUS Biopharmaceuticals, Inc.Non-Employee Stock Option (Right to Buy)A Award | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)D Disposition to Issuer | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)D Disposition to Issuer | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)D Disposition to Issuer | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)D Disposition to Issuer | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCJ Other | −$765K |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)D Disposition to Issuer | — |
| 2014-07-15 | EPIRUS Biopharmaceuticals, Inc.F Tax Payment | −$172K |
| 2014-02-27 | CUBIST PHARMACEUTICALS INCS Sale | −$400K |
| 2014-02-27 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)M Exercise/Conversion | — |
| 2014-02-27 | CUBIST PHARMACEUTICALS INCM Exercise/Conversion | +$91.1K |
| 2014-02-10 | EPIRUS Biopharmaceuticals, Inc.Stock Option (Right to Buy)A Award | — |
| 2014-02-10 | EPIRUS Biopharmaceuticals, Inc.A Award | — |
| 2014-01-15 | EPIRUS Biopharmaceuticals, Inc.F Tax Payment | −$30K |
| 2014-01-03 | EPIRUS Biopharmaceuticals, Inc.F Tax Payment | −$9,802.7 |
| 2013-06-12 | CUBIST PHARMACEUTICALS INCA Award | — |
| 2013-06-12 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award | — |
| 2013-06-12 | CUBIST PHARMACEUTICALS INCRestricted Stock UnitsA Award | — |
Recent filings
- 4CORRIGAN MARK0001193125-26-417234SEC(opens sec.gov)
- 4CORRIGAN MARK0001193125-25-314735SEC(opens sec.gov)
- 4CORRIGAN MARK0000950170-25-108291SEC(opens sec.gov)
- 4CORRIGAN MARK0000950170-24-097286SEC(opens sec.gov)
- 4CORRIGAN MARK0001062993-24-012664SEC(opens sec.gov)
- 4CORRIGAN MARK0000899243-23-017913SEC(opens sec.gov)
- 4CORRIGAN MARK0001062993-23-015143SEC(opens sec.gov)
- 4CORRIGAN MARK0000899243-22-029095SEC(opens sec.gov)
- 4CORRIGAN MARK0001104659-22-086277SEC(opens sec.gov)
- 4CORRIGAN MARK0000899243-21-033522SEC(opens sec.gov)
- 4CORRIGAN MARK0001104659-21-098423SEC(opens sec.gov)
- 4CORRIGAN MARK0001104659-21-077205SEC(opens sec.gov)
- 4CORRIGAN MARK0000899243-20-023093SEC(opens sec.gov)
- 4CORRIGAN MARK0000899243-19-023038SEC(opens sec.gov)
- 4CORRIGAN MARK0001104659-19-043346SEC(opens sec.gov)
Companies
- CoLucid Pharmaceuticals, Inc.Director
- CUBIST PHARMACEUTICALS INCDirector
- EPIRUS Biopharmaceuticals, Inc.Director
- Nabriva Therapeutics Legacy plcDirector
- Nabriva Therapeutics plcDirector
- NOVELION THERAPEUTICS INC.Director
- Sunovion Pharmaceuticals Inc.Executive VP, R&D
- TREVENA INCDirector
- Wave Life Sciences, Inc.DirectorWVE
Address
C/O WAVE LIFE SCIENCES, INC., 733 CONCORD AVE.
CAMBRIDGE, MA, 02138